NGR-TNF Engineering with an N‑Terminal Serine Reduces Degradation and Post-Translational Modifications and Improves Its Tumor-Targeting Activity
Published: 6 October 2023| Version 1 | DOI: 10.17632/mg2s6sjscn.1
Contributor:
Description
Raw data and original images for the article entitled "NGR-TNF Engineering with an N-Terminal Serine Reduces Degradation and Post-Translational Modifications and Improves Its Tumor-Targeting Activity" by Angelo Corti, Anna Maria Gasparri, Angelina Sacchi, Barbara Colombo, Matteo Monieri, Eltjona Rrapaj, Andrés J. M. Ferreri, and Flavio Curnis Molecular Pharmaceutics 2020 17 (10), 3813-3824, DOI: 10.1021/acs.molpharmaceut.0c00579
Files
Institutions
Ospedale San Raffaele
Categories
Cancer, Integrin, Aminopeptidases, Sequence Motif, Tumor Necrosis Factor, Protein Deamidation
Funding
Ministero della Salute
RF-2016-02361054
Associazione Italiana per la Ricerca sul Cancro
IG-23470
Associazione Italiana per la Ricerca sul Cancro
IG-22737